News & Updates

Gestational diabetes linked to altered gut microbiome and larger head circumference in male offspring
Gestational diabetes linked to altered gut microbiome and larger head circumference in male offspring
28 Aug 2024 byKanas Chan

Gestational diabetes mellitus (GDM) not only disrupts the gut microbiome of mothers and their infants, but is also linked to increased head circumference in male offspring, researchers from the Chinese University of Hong Kong (CUHK) have shown.

Gestational diabetes linked to altered gut microbiome and larger head circumference in male offspring
28 Aug 2024
Does obesity raise mortality risk in COVID-19 patients?
Does obesity raise mortality risk in COVID-19 patients?
22 Aug 2024

Obesity does not appear to elevate the risk of death in critically ill patients with COVID-19, results of a study have shown. In addition, patients with BMI <25 kg/m2 have a higher rate of mortality than those with greater BMI levels.

Does obesity raise mortality risk in COVID-19 patients?
22 Aug 2024
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024 byJairia Dela Cruz

Individuals with type 2 diabetes (T2D) treated in routine clinical care appear to fare better with glucagon-like peptide-1 receptor agonists (GLP-1RAs) than with dipeptidyl peptidase-4 inhibitors (DPP-4is), with GLP-1Ras being associated with lower rates of hyperkalemia and renin-angiotensin system inhibitor (RASi) medication discontinuation, as shown in an observational study.

GLP-1RAs outperform DPP-4is in preventing hyperkalemia, RASi therapy discontinuation
20 Aug 2024